Literature DB >> 28520871

Pharmaceutical Marketing for Rare Diseases: Regulating Drug Company Promotion in an Era of Unprecedented Advertisement.

Sham Mailankody1, Vinay Prasad2.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28520871     DOI： 10.1001/jama.2017.5784

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  4 in total

Review 1.  Overdiagnosis in primary care: framing the problem and finding solutions.

Authors:  Minal S Kale; Deborah Korenstein
Journal:  BMJ       Date:  2018-08-14

2.  Trade Agreements and Direct-to-Consumer Advertising of Pharmaceuticals.

Authors:  Deborah Gleeson; David B Menkes
Journal:  Int J Health Policy Manag       Date:  2018-02-01

3.  Income-Generating Processes of Free Web-Based Digital Health Tools to Engage Patients: Qualitative Analysis.

Authors:  Claudia Lai; Raisa Deber; Alejandro R Jadad; Aviv Shachak
Journal:  J Med Internet Res       Date:  2021-02-03       Impact factor: 5.428

4.  Recommendations for the ethical conduct of vaccination awareness campaigns by biopharmaceutical companies.

Authors:  Claar van der Zee; Veronique Delpire; Volker Vetter; Tatjana Poplazarova
Journal:  Hum Vaccin Immunother       Date:  2022-02-03       Impact factor: 3.452
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.